NLM Logo

MV26PD protocol MeSH Supplementary Concept Data 2023


MeSH Supplementary
MV26PD protocol
Unique ID
C057981
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C057981
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Dexamethasone
Methotrexate
Procarbazine
Teniposide
Frequency
1
Note
chemotherapy protocol consisting of methotrexate, VM-26 (teniposide), procarbazine, & dexamethasone; used in treatment of patients with non-Hodgkin's lymphoma
Source
Med Pedatr Oncol 1988;16(6):375
Date of Entry
1989/01/19
Revision Date
2000/11/30
MV26PD protocol Preferred
page delivered in 0.005s